NL7201471A - - Google Patents

Info

Publication number: NL7201471A
Authority: NL; Netherlands

Application number

NL7201471A

Other versions

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1971-02-16

Filing date

1972-02-04

Publication date

1972-08-18

1972-02-04 Application filed filed Critical

1972-08-18 Publication of NL7201471A publication Critical patent/NL7201471A/xx

1984-01-02 Publication of NL174349B publication Critical patent/NL174349B/xx

1984-06-01 Application granted granted Critical

1984-06-01 Publication of NL174349C publication Critical patent/NL174349C/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/65—One oxygen atom attached in position 3 or 5
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pyridine Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NLAANVRAGE7201471,A 1971-02-16 1972-02-04 Werkwijze voor de bereiding van derivaten van 2-amino-1-pyridylethanol en werkwijze voor de bereiding van preparaten die ze bevatten. NL174349C (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11587871A	1971-02-16	1971-02-16
US25664172A	1972-05-25	1972-05-25

Publications (3)

Publication Number	Publication Date
NL7201471A true NL7201471A (fr)	1972-08-18
NL174349B NL174349B (nl)	1984-01-02
NL174349C NL174349C (nl)	1984-06-01

Family

ID=26813670

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NLAANVRAGE7201471,A NL174349C (nl)	1971-02-16	1972-02-04	Werkwijze voor de bereiding van derivaten van 2-amino-1-pyridylethanol en werkwijze voor de bereiding van preparaten die ze bevatten.

Country Status (9)

Country	Link
US (2)	US3700681A (fr)
AT (1)	AT315842B (fr)
BE (1)	BE778771A (fr)
CA (1)	CA978962A (fr)
CH (1)	CH541560A (fr)
DE (2)	DE2204195C2 (fr)
FR (1)	FR2125309B1 (fr)
GB (2)	GB1367668A (fr)
NL (1)	NL174349C (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR207639A1 (es) *	1973-12-26	1976-10-22	Pfizer	Un procedimiento para preparar pirido (3,2-d)1,3-dioxin-6-epoxietanos y compuestos intermediarios desprovistos de actividad terapeutica
US3952101A (en) *	1975-04-14	1976-04-20	Smithkline Corporation	α-Amino methyl-5-hydroxy-2-pyridinemethanols
US4011231A (en) *	1975-10-03	1977-03-08	Pfizer Inc.	2-Phenyl-6-(1-hydroxy-2-t-butylaminoethyl)-4H-pyrido[3,2-d]-1,3-dioxin maleate and its use as an intermediate
SE7708307L (sv) *	1976-08-26	1978-02-27	Pfizer	Forfarande for framstellning av farmaceutiska kompositioner anvendbara sasom bronkodilatorer
US4175128A (en) *	1979-01-03	1979-11-20	Pfizer Inc.	Method for treating congestive heart failure
SU1194273A3 (ru) *	1981-02-09	1985-11-23	Пфайзер Инк (Фирма)	Способ получени пирбутерола или его аналогов
US4632992A (en) *	1981-02-09	1986-12-30	Pfizer Inc.	Intermediates for preparing pirbuterol and analogs
GB8414559D0 (en) *	1984-06-07	1984-07-11	Scras	Pyridine derivatives
EP0220054A3 (fr) *	1985-10-16	1987-12-02	Glaxo Group Limited	Dérivés d'éthanolamine
US4601897A (en) *	1985-11-06	1986-07-22	Pfizer Inc.	Prazosin-pirbuterol combination for bronchodilation
WO1993000090A1 (fr) *	1991-06-26	1993-01-07	Sepracor, Inc.	Methodes et compositions pour le traitement des troubles pulmonaires et cardiaques avec du pirbuterol optiquement pur (+)
WO1993000091A1 (fr) *	1991-06-26	1993-01-07	Sepracor, Inc.	Procedes et compositions pour le traitement de troubles pulmonaires et cardiaques utlisant un (-)pirbuterol optiquement pur
US7105152B1 (en)	1991-12-18	2006-09-12	3M Innovative Properties Company	Suspension aerosol formulations
US7101534B1 (en)	1991-12-18	2006-09-05	3M Innovative Properties Company	Suspension aerosol formulations
RU2387646C2 (ru) *	2003-08-29	2010-04-27	Рэнбакси Лабораториз Лимитед	Ингибиторы фосфодиэстеразы типа-iv
US20070259874A1 (en) *	2003-11-26	2007-11-08	Palle Venkata P	Phosphodiesterase Inhibitors
WO2005092860A1 (fr) *	2004-03-23	2005-10-06	Pfizer Limited	Composes servant au traitement de maladies
WO2007031838A1 (fr)	2005-09-16	2007-03-22	Ranbaxy Laboratories Limited	Pyrazolo[3,4-b]pyridines substituees en tant qu'inhibiteurs de la phosphodiesterase
AU2006305620A1 (en) *	2005-10-19	2007-04-26	Ranbaxy Laboratories Limited	Compositions of phosphodiesterase type IV inhibitors
WO2007045979A1 (fr)	2005-10-19	2007-04-26	Ranbaxy Laboratories Limited	Compositions pharmaceutiques d'antagonistes du recepteur muscarinique
JO2868B1 (en)	2006-08-22	2015-03-15	رانبكسي لابوراتوريز ليمتد	Inhibitors of metabolic protein protein enzyme
EA200900472A1 (ru) *	2006-09-22	2009-10-30	Ранбакси Лабораторис Лимитед	Ингибиторы фосфодиэстеразы iv типа
WO2008035316A2 (fr) *	2006-09-22	2008-03-27	Ranbaxy Laboratories Limited	Inhibiteurs de phosphodiestérase
EP1958947A1 (fr)	2007-02-15	2008-08-20	Ranbaxy Laboratories Limited	Inhibiteurs de la phosphodiestérase de type 4
SI2124944T1 (sl) *	2007-03-14	2012-05-31	Ranbaxy Lab Ltd	Derivati pirazolo b piridina kot inhibitorji fosfodiesteraze
US20110130403A1 (en) *	2007-03-14	2011-06-02	Ranbaxy Laboratories Limited	Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
EP2111861A1 (fr)	2008-04-21	2009-10-28	Ranbaxy Laboratories Limited	Compositions d'inhibiteurs de type IV de la phosphodiestérase
CN103119030A (zh)	2010-07-30	2013-05-22	兰贝克赛实验室有限公司	基质金属蛋白酶抑制剂
US20140148459A1 (en)	2010-09-24	2014-05-29	Ranbaxy Laboratories Limited	Matrix metalloproteinase inhibitors
CN103848781B (zh) *	2012-11-30	2017-06-30	重庆华邦制药有限公司	高选择性氧化二羟甲基吡啶中一个羟甲基的方法
MY176727A (en)	2012-12-03	2020-08-20	Pfizer	Selective androgen receptor modulators

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1089189A (en) *	1964-09-23	1967-11-01	Koninklijke Pharma Fab Nv	Ethers of -(2-pyridyl)benzyl alcohols

1971
- 1971-02-16 US US115878A patent/US3700681A/en not_active Expired - Lifetime
- 1971-11-04 GB GB5141671A patent/GB1367668A/en not_active Expired
- 1971-11-04 GB GB3749773A patent/GB1367669A/en not_active Expired
1972
- 1972-01-27 AT AT63972A patent/AT315842B/de not_active IP Right Cessation
- 1972-01-29 DE DE2204195A patent/DE2204195C2/de not_active Expired
- 1972-01-29 DE DE2265581A patent/DE2265581C2/de not_active Expired
- 1972-02-01 BE BE778771A patent/BE778771A/fr not_active IP Right Cessation
- 1972-02-02 FR FR7203470A patent/FR2125309B1/fr not_active Expired
- 1972-02-03 CA CA133,875A patent/CA978962A/en not_active Expired
- 1972-02-04 CH CH164872A patent/CH541560A/fr not_active IP Right Cessation
- 1972-02-04 NL NLAANVRAGE7201471,A patent/NL174349C/xx not_active IP Right Cessation
- 1972-05-25 US US00256641A patent/US3763173A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
NL174349B (nl)	1984-01-02
GB1367668A (en)	1974-09-18
AT315842B (de)	1974-06-10
FR2125309A1 (fr)	1972-09-29
FR2125309B1 (fr)	1976-05-14
US3763173A (en)	1973-10-02
DE2204195A1 (de)	1972-08-17
GB1367669A (en)	1974-09-18
CH541560A (fr)	1973-10-31
US3700681A (en)	1972-10-24
DE2204195C2 (de)	1981-11-19
BE778771A (fr)	1972-08-01
NL174349C (nl)	1984-06-01
CA978962A (en)	1975-12-02
DE2265581C2 (de)	1982-07-01

Legal Events

Date	Code	Title	Description
1992-03-16	V4	Discontinued because of reaching the maximum lifetime of a patent

Publication	Publication Date	Title
FR2125309B1 (fr)	1976-05-14
ATA136472A (fr)	1973-12-15
AU2691671A (fr)	1972-09-28
AU2564071A (fr)	1972-08-24
AU2952271A (fr)	1972-12-07
AU2684071A (fr)	1972-09-28
AU2941471A (fr)	1972-11-30
AU2894671A (fr)	1972-11-23
AU3005371A (fr)	1972-12-21
AU2726271A (fr)	1972-10-05
AU2485671A (fr)	1972-08-03
AU2399971A (fr)	1972-07-06
AU2963771A (fr)	1972-12-07
AU2455871A (fr)	1972-07-27
AU2755871A (fr)	1972-10-19
AU2486471A (fr)	1972-08-03
AU2837671A (fr)	1972-11-09
AU3038671A (fr)	1973-01-04
AU1109576A (fr)	1976-04-29
AU2836771A (fr)	1972-11-09
AU2577671A (fr)	1972-08-24
AU2880771A (fr)	1972-11-16
AU2503871A (fr)	1972-08-10
AU2740271A (fr)	1972-10-12
AU2885171A (fr)	1972-11-16